Cite
229 Nitrosodimethylamine and methylamine, novel metabolites in scleroderma, may drive dual pathogenic processes of endothelial cell apoptosis and fibrosis
MLA
Durga Prasanna Misra, et al. “229 Nitrosodimethylamine and Methylamine, Novel Metabolites in Scleroderma, May Drive Dual Pathogenic Processes of Endothelial Cell Apoptosis and Fibrosis.” Rheumatology, vol. 58, Apr. 2019. EBSCOhost, https://doi.org/10.1093/rheumatology/kez107.045.
APA
Durga Prasanna Misra, Atul Rawat, Durgesh Dubey, Vikas Agarwal, Sakir Ahmed, Dinesh Kumar, & Mohit Kumar Rai. (2019). 229 Nitrosodimethylamine and methylamine, novel metabolites in scleroderma, may drive dual pathogenic processes of endothelial cell apoptosis and fibrosis. Rheumatology, 58. https://doi.org/10.1093/rheumatology/kez107.045
Chicago
Durga Prasanna Misra, Atul Rawat, Durgesh Dubey, Vikas Agarwal, Sakir Ahmed, Dinesh Kumar, and Mohit Kumar Rai. 2019. “229 Nitrosodimethylamine and Methylamine, Novel Metabolites in Scleroderma, May Drive Dual Pathogenic Processes of Endothelial Cell Apoptosis and Fibrosis.” Rheumatology 58 (April). doi:10.1093/rheumatology/kez107.045.